Prevalência de soropositividade para toxoplasmose em gestantes

Varella, Ivana S; Wagner, Mário B; Darela, Alessandra C; Nunes, Leandro M; Müller, Regina W.
J. pediatr. (Rio J.) ; 79(1): 69-74, jan.-fev. 2003. tab
Artículo en Portugués | LILACS | ID: lil-336710

Documentos relacionados

  1. Intervención terapéutica en niños con secuelas de toxoplasmosis
  2. Both maternal IFNγ exposure and acute prenatal infection with Toxoplasma gondii activate fetal hematopoietic stem cells.
  3. Are alterations in melatonin and inflammatory cytokine serum levels linked with recurrent abortion in pregnant women with acute toxoplasmosis: The interacted nexus.
  4. Seroprevalence of Toxoplasmosis in Puerperal Women Treated at a Tertiary Referral Hospital.
  5. Toxoplasma gondii Causes Adverse Pregnancy Outcomes by Damaging Uterine Tissue-Resident NK Cells That Secrete Growth-Promoting Factors.
  6. Comparison of the prevalence of risk factors for Toxoplasma Gondii infection among pregnant women in rural and urban areas in Poland.
  7. Soroprevalência de Anticorpos anti-Toxoplasma gondii em Amostras de Gestantes no Pré-Natal
  8. The apicoplast is important for the viability and persistence of <i>Toxoplasma gondii</i> bradyzoites.
  9. Correlation of toxoplasmosis with small­for­gestational­age newborns.
  10. Could PLATELIA Toxo IgM be the new gold standard for the serological diagnosis of congenital toxoplasmosis: a French multicenter study.